Basic Information
Vie Pharma is a regional specialty company aimed at bridging access gaps and collaborating with global pharmaceutical and biotechnology companies to license and commercialize innovative drugs, biologics, and other healthcare solutions approved by the FDA or EMA into the Middle East (ME). In doing so, Vie Pharma provides its partners with one-stop solutions for multi-country access across a vast region with a growing economy but complex regulatory and access barriers. Primary healthcare, psychiatry, gastroenterology, cosmetic surgery, immunological wounds, and wound healing are among Vie Pharma’s current strategic focuses. The existing portfolio is designed to address unmet medical needs in the region, allowing the company to not only gain a solid market share but also help patients access these much-needed medications. Future expansion plans include offering our own branded products through establishing manufacturing and development capabilities. Vie Pharma's innovative business model and efficient commercialization scope have been built by successful and respected industry leaders with strong local and international track records. Moreover, the Vie Pharma team brings years of experience in regulatory affairs, medical, pharmacovigilance, and commercial capabilities, which have been accumulated through extensive experience in multinational pharmaceutical companies. The team has also established strong connections with a wide range of partners and key stakeholders both within and outside the region and offers flexible approaches to joint ventures and partnerships. This integrated and unique regional expertise strategy, combined with a robust international network, positions Vie Pharma as the preferred regional partner for pharmaceutical, biotech, and other healthcare companies seeking entry into the rapidly growing Middle Eastern market.